重症全身性炎症反应综合征患者营养风险筛查及补硒治疗分析

发布时间：2018-07-29 06:30

【摘要】：目的探讨重症全身性炎症反应综合征患者营养风险筛查情况和补硒治疗效果。方法 54例重症全身性炎症反应综合征患者,其中23例存在营养不良风险,作为营养不良风险组;另31例营养正常,作为营养正常组。将营养不良风险组患者随机分为对照组(12例)和观察组(11例)。对照组采用常规治疗,观察组采用补硒治疗,比较两组营养指标、并发症和急性生理与慢性健康评分表(APACHEⅡ)评分情况。结果54例患者中23例存在营养不良风险,发生率为42.59%;营养不良风险组的BMI、血清白蛋白(ALB)、血红蛋白(Hb)和红细胞计数均低于营养正常组(P0.05);观察组治疗后第14天的ALB、Hb高于对照组(P0.05);观察组腹胀、腹泻、高血糖和胃肠出血等并发症发生率均低于对照组(P0.05);观察组治疗14d后的APACHEⅡ评分低于对照组(P0.05)。结论重症全身性炎症反应综合征患者极易发生营养不良风险,及时给予补硒治疗可有效改善患者营养状况,降低并发症发生率,促进早日康复。
[Abstract]:Objective to investigate the nutritional risk screening and therapeutic effect of selenium supplementation in patients with severe systemic inflammatory response syndrome. Methods 54 patients with severe systemic inflammatory response syndrome, 23 of them were at risk of malnutrition, the other 31 had normal nutrition. Patients at risk of malnutrition were randomly divided into control group (n = 12) and observation group (n = 11). The control group was treated with routine therapy, and the observation group was treated with selenium supplementation. The nutritional indexes, complications and acute physiological and chronic health score (APACHE 鈪，

本文编号：2151826